Engineers Gate Manager LP

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,259,260

+$979,714 QoQ

Shares Held

33,842

+119.7% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#113

of 252 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. CLDX ranks #46 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,259,260	33,842	+119.7%	Shares	Sole	2026-08-14
2025-03-31	$279,546	15,402	+34.1%	Shares	Sole	2025-05-15
2024-12-31	$290,327	11,489	-70.1%	Shares	Sole	2025-02-14
2024-09-30	$1,308,139	38,486	+396.3%	Shares	Sole	2024-11-14
2024-06-30	$286,975	7,754	-70.9%	Shares	Sole	2024-08-14
2024-03-31	$1,116,653	26,606	+193.3%	Shares	Sole	2024-05-15
2023-12-31	$359,716	9,070	-33.6%	Shares	Sole	2024-02-14
2023-09-30	$375,730	13,653	+66.0%	Shares	Sole	2023-11-14
2023-03-31	$296,007	8,227	-33.2%	Shares	Sole	2023-05-15
2022-09-30	$346,230	12,317	+73.8%	Shares	Sole	2022-11-14
2022-03-31	$241,349	7,086	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.